Advertisement

Diltiazem Injection

[31 July 2014]

Products Affected - Description

Diltiazem Injection, Akorn
5 mg/mL 10 mL vials (NDC 17478-0937-10)
 
Diltiazem Injection, Bedford, Ben Venue Laboratories (formerly Bedford product)
5 mg/mL 5 mL vials (NDC 55390-0565-05)
5 mg/mL 10 mL vials (NDC 55390-0565-10)
5 mg/mL 25 mL vials (NDC 55390-0565-30)
 
Diltiazem Injection, Hospira
5 mg/mL, 5 mL vials (NDC 00409-1171-01)
5 mg/mL, 10 mL vials (NDC 00409-1171-02) 
100 mg ADD-Vantage vials (NDC 00409-4350-03)

Reason for the Shortage

  • Ben Venue stopped product in its plant in Bedford, Ohio and closed in July 2014.
  • Hospira states the reasons for the shortage are manufacturing delays and increases in demand.
  • West-Ward had diltiazem injection on shortage due to manufacturing delays caused by increased demand due to current market conditions.
  • Akorn states the reason for the shortage is increased demand due to market conditions.
  • Teva discontinued all diltiazem presentations in March, 2011.
  • Biovail discontinued Cardizem Lyo-Ject in 2007 due to business reasons.

Available Products

Diltiazem Injection, Akorn
5 mg/mL 5 mL vials (NDC 17478-0937-05)
5 mg/mL, 25 mL vials (NDC 17478-0937-25)
 
Diltiazem Injection, West-Ward
5 mg/mL, 5 mL vials (NDC 00641-6013-10)
5 mg/mL, 10 mL vials (NDC 00641-6014-10)
5 mg/mL, 25 mL vials (NDC 00641-6015-10)

Estimated Resupply Dates

  • Akorn has diltiazem 10 mL vials on back order and the company cannot estimate a release date.
  • Hospira has diltiazem 5 mL vials, 10 mL vials, and 100 mg ADD-Vantage vials on back order and the company estimates a release date of July 2014.

Related Shortages

Updated

July 31, 2014; July 17, 2014; June 30, 2014; June 19, 2014; June 13, 2014; May 28, 2014; May 27, 2014; May 13, 2014; April 25, 2014; April 11, 2014; April 9, 2014; March 28, 2014; March 3, 2014; February 21, 2014; February 10, 2014; November 11, 2013; October 14, 2013; September 5, 2013; August 12, 2013; August 6, 2013; July 1, 2013; June 21, 2013; June 6, 2013; March 22, 2013; February 26, 2013; Febraury 22, 2013; January 3, 2013; November 28, 2012; October 22, 2012; September 26, 2012; August 17, 2012; July 13, 2012; June 28, 2012; May 18, 2012; May 10, 2012; April 20, 2012; April 10, 2012; April 4, 2012; March 14, 2012; February 16, 2012; February 3, 2012; January 18, 2012; February 17, 2011; University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement